47.6%, [11] ), and our analysis indicates that the significant association is lost in first-order correlations controlling for the highly significant association between ErbB2 and the cell proliferation marker Ki67.
← all excerpts
ErbB2 receptor immunoreactivity in prostate cancer: relationship to the androgen receptor, disease severity at diagnosis and disease outcome.
1
—
—